Skip to main content
Medicure Inc logo

Medicure Inc — Investor Relations & Filings

Ticker · MPH ISIN · CA58469E4085 LEI · 9845007T999BF377B627 TSXV Manufacturing
Open in API
Filings indexed 293 across all filing types
Latest filing 2021-11-22 Regulatory Filings
Country CA Canada
Listing TSXV MPH

About Medicure Inc

https://www.medicure.com/

Medicure Inc. is a value-based pharmaceutical company specializing in the research, clinical development, and commercialization of human therapeutics. The company is primarily focused on developing and commercializing innovative and affordable medicines within the cardiovascular therapeutic area. Medicure's core mission is to serve patients by delivering safe and efficacious life-changing medicines, with a strategic focus on the U.S. market. It aims to offer a growing portfolio of products and services, ensuring patient access to necessary care.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2021-11-22 English
Interim financial statements/report – English.pdf
Regulatory Filings
2021-11-22 English
News release - English.pdf
Regulatory Filings
2021-11-22 English
News release - English.pdf
Regulatory Filings
2021-11-04 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Management's Discussion and Analysis for the six months ended June 30, 2021' and contains detailed management commentary on business operations, financial performance, and forward-looking statements. It references the six-month period ended June 30, 2021, and includes substantive financial and operational analysis. The document is prepared by management and is not an announcement or a brief summary. It fits the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial data and analysis. There is no indication that this is merely an announcement or a certification, so it should not be classified as RPA or RNS. Therefore, the correct classification is IR with high confidence. H1 2021
2021-08-27 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a FORM 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate by the CFO of Medicure Inc. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended June 30, 2021. The document is primarily an officer certification letter and does not contain actual financial statements or substantive financial data. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself. The document length is under 5,000 characters and it is a certification, not the report itself.
2021-08-27 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.